Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drug-sensitive FGFR2 mutations in endometrial carcinoma.

Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc Natl Acad Sci U S A. 2008 Jun 24; 105(25):8713-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.